insights_auto
Bakit bumaba ang MEOBF 13.47%?
Tingnan ang Higit pang Detalyechevron_right
MEOBF:OTCMKTS
Mesoblast Ltd
$1.32
arrow_downward
-13.47%(-0.21) 1D
Okt 14, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa MEOBF...
Buksan
$1.32
Mataas
$1.32
Mababa
$1.32
Mkt. cap
1.84B
Avg. na dami
391.00
Dami
300.00
Mataas nang 52-wk
$2.59
Mababa nang 52-wk
$1.14
Beta
1.68
Mga natitirang share
1.30B
Bilang ng mga empleyado
108
Buksan
$1.32
Mataas
$1.32
Mababa
$1.32
Mkt. cap
1.84B
Avg. na dami
391.00
Dami
300.00
Mataas nang 52-wk
$2.59
Mababa nang 52-wk
$1.14
Beta
1.68
Mga natitirang share
1.30B
Bilang ng mga empleyado
108
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Kalkine
·
1 araw ang nakalipas
Mesoblast Applies to Quote 2,550,000 Ordinary Shares Issued Under Employee Incentive Scheme on 3 September 2026
TipRanks
·
2 araw ang nakalipas
Mesoblast Posts First Full-Year Ryoncil Revenue Surge and Files 2026 Annual Report
Stock Titan
·
2 araw ang nakalipas
From US$17.2M a year earlier, FY2026 revenue climbs at Mesoblast (MESO).
Profile
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004. Wikipedia
Tungkol sa Mesoblast Ltd